7. 专有技术平台
Asia Cell & Gene Therapeutics Group Due Diligent Data Room
公司经过十余年专注CGT新药研发，已建立先进和稳定CGT新药相关技术平台，其可持续不断地在CGT前沿领域研发产生“医疗为满足”的安全有效的CGT新药。
After more than a decade of dedicated focus on CGT novel drug R&D, the Company has established advanced and robust technology platforms, enabling the continuous development of safe and effective CGT new drugs that address unmet medical needs at the forefront of the CGT field.
点击以下各技术平台名称阅读详细内容。如有任何问题，请指明编码随时询问我们。
Click on the names of the technology platforms below to read the detailed information. If you have any questions, please refer to the relevant code and feel free to contact us at any time.
- 多个功能基因敲除/敲入 Multiple functional gene knockouts / knock-ins
- 降低免疫原性 Reduced immunogenicity
- 延长体内活性 Prolonged in vivo activity
- 控制细胞存活，提高安全性 Controlled cell survival to enhance safety